Stuart L. Rosenthal

Stuart L. Rosenthal

Stuart L. Rosenthal

Stuart Rosenthal is a partner in Goodwin’s Private Equity Group and the head of the group’s Healthcare Services vertical. He specializes in representing private equity sponsors and their portfolio companies in a variety of transactions, including leveraged buyouts, leveraged recapitalizations, growth equity investments, mergers and acquisitions, joint ventures, securities laws and general corporate matters.

Mr. Rosenthal’s experience ranges from the representation of early stage growth companies on equity and debt financings, equity incentive compensation and general corporate matters to the representation of later stage private companies on recapitalizations, strategic investments and M&A transactions. His industry expertise includes healthcare services, technology and business services.

Professional Activities

Mr. Rosenthal is a member of the Massachusetts, New York and American Bar Associations.

Professional Experience

Prior to attending law school, Mr. Rosenthal worked at State Street Bank and Trust Company as a mutual fund accountant.


Mr. Rosenthal is listed in Chambers USA: America’s Leading Lawyers for Business. He has also been recognized as a New York Metro “Rising Star” by Super Lawyers and was also an Editor and a Comment Editor of the University of Pennsylvania Law Review.

Areas of Practice


Mr. Rosenthal represents leading private equity firms, including Behrman Capital, Ferrer Freeman and Co., Primus Capital Partners, Great Hill Partners, SV Life Sciences, W Capital Partners, Pinebridge Investments and Veronis Suhler Stevenson, as well as emerging technology companies such as Cureatr, Inc. His recent representative transactions include:

  • Behrman Capital in connection with its:
    • Sale of five companies from Behrman Capital III L.P., a $1.2 billion buyout fund that closed in 2001, to a newly created investment vehicle backed largely by Canada Pension Plan Investment Board
    • Sale of Ark Holding Company, an owner/operator of assisted living and skilled nursing facilities, for $525 million through a sale/leaseback arrangement with Omega Healthcare Investors and a subsequent merger with 4 West
    • Sale of Peacock Engineering Company, a packaging service company for leading food industry consumer products companies, to Charlesbank Capital Partners
  • Ferrer Freeman & Co in connection with its:
    • Sale of Ernest Healthcare, an owner/operator of acute rehabilitation and long term care acute facilities, to Medical Properties Trust, Inc. (NYSE: MPW) for $400 million
    • Sale of Amerita, a provider of in-home specialty infusion services, to PharMerica Corporation (NYSE: PMC) for $85 million
    • Sale of Genova Diagnostics, a global specialty clinical lab, to Levine Leichtman Capital Partners
    • Leveraged acquisition of Arcadia Solutions, a technology consulting service provider for healthcare payors and providers, from Marquette Technology Companies, LLC
  • Primus Capital Partners in connection with its:
    • Acquisition of hyperWallet Systems, a Vancouver based electronic payment processing company
    • Acquisition of Emmi Solutions, a provider of SaaS based solutions to healthcare payors and providers
    • Minority growth capital investment in Cardinal Commerce, a provider of authentication and security software solutions for e-commerce and mobile commerce companies
  • W Capital Partners in connection with its:
    • Primary and direct secondary investments in Mindbody, Inc., a SaaS technology provider for the health, wellness and beauty industries
    • Primary and direct secondary investments in Tremor Media, a digital video technology company
  • Great Hill Partners and Primus Capital Partners in their sale of Sterilmed, Inc., a medical device reprocessing company, to Ethicon Endo-Surgery, a Johnson & Johnson Company
  • TA Associates in its sale of Global 360, a business process and document management software provider, to OpenText (NasdaqGS: OTEX) for $260 million
  • SV Life Sciences in connection with its:
    • Acquisition of Ximedica, a medical device contract development company
    • Acquisition of Health Essentials, a group of affiliated healthcare services companies focused on managing the costs of post-acute and hospice services
  • Cureatr, Inc. in its convertible note and Series A financings



J.D., 1998
University of Pennsylvania Law School
B.A., 1993
Emory University



New York
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Search Other Lawyers